Tyrosine Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy EGFR Serine-Threonine Kinase Inhibitors Heat Shock Protein Inhibitors Threonine-Tyrosine Kinase Inhibitors | Non Small Cell Lung Cancer | Lung Adenocarcinoma | Lung Non-Small Cell Squamous Cancer | Neuroendocrine Tumor | Salivary Gland Cancer | Breast Cancer | Ovarian Cancer | Melanoma |
---|---|---|---|---|---|---|---|---|
alectinib | ||||||||
lorlatinib | ||||||||
crizotinib | ||||||||
atezolizumab | ||||||||
brigatinib | ||||||||
ensartinib | ||||||||
gilteritinib | ||||||||
durvalumab | ||||||||
ADX-1612 | ||||||||
ceritinib | ||||||||
ceritinib + U0126 | ||||||||
MTI-31 | ||||||||
Immunotherapy | ||||||||
Tyrosine kinase inhibitor | ||||||||
GC |